AmerisourceBergen aims to connect trial sponsors with cancer practices
Independent specialty practices are an untapped recruitment opportunity for clinical trials, says AmerisourceBergen, which has launched a tool that connects drug developers with oncology practices. The technology–called Clinical Trial Navigator–is a software platform that supports recruitment for biopharmaceutical companies’ clinical trials, according to AmerisourceBergen spokeswoman Francesca LaMonaca. The platform will help connect biopharma companies with independent oncology practice groups across the country, LaMonaca told Fierce Biotech. She added that AmerisourceBergen already works with thousands of independent specialty physician practices nationwide.
For the full article, please visit FierceCRO.